Enteral Nutrition Global Market Report 2024

The enteral nutrition market size has grown strongly in recent years. It will grow from $11.55 billion in 2023 to $12.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historical period can be ascribed to clinical requirements, utilization in hospital and clinical environments, surgical interventions, advancements in feeding tube technology, and heightened awareness.

The enteral nutrition market size is expected to see strong growth in the next few years. It will grow to $16.8 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The anticipated growth in the forecast period can be linked to a focus on patient-centric care, the prevalence of chronic health conditions, the trend toward home-based care, the adoption of personalized nutrition approaches, and the increase in gastrointestinal disorders. Major trends expected in the forecast period include the refinement of administration techniques, advancements in tube placement technologies, the introduction of modular and customized nutrition solutions, the development of immunonutrition, and the availability of home enteral feeding kits.

The rising prevalence of chronic diseases is expected to generate increased demand for enteral nutrition. Chronic or non-communicable diseases (NCDs) are prolonged conditions that typically progress slowly and persist over an extended period, encompassing cardiovascular diseases, diabetes, respiratory diseases, cancer, chronic kidney disease, neurological diseases, rheumatoid arthritis, and other autoimmune diseases. Enteral nutrition serves as a supportive measure for patients facing challenges in eating or maintaining adequate nutrition due to the disease or its treatments. For example, in 2023, the American Cancer Society, Inc reported an increase in estimated new cases of liver cancer in females in the United States from 12,660 in 2022 to 13,230 in 2023. Additionally, statistics published by the International Diabetes Federation in December 2021 revealed that 537 million adults (20-79 years) were living with diabetes in 2021, with 6.7 million people dying from diabetes in that year. It is anticipated that by 2030, 643 million people worldwide will have diabetes. Hence, the rising prevalence of chronic diseases is a driving factor for the enteral nutrition market.

The growth of the aging population is expected to drive the expansion of the enteral nutrition market in the future. The term 'aging population' refers to a demographic trend characterized by an increasing proportion of elderly individuals within a society or population. The aging population turns to enteral nutrition to address nutritional deficiencies, support optimal health, and manage age-related conditions or medical treatments that may hinder regular food intake. For instance, as of October 2022, the World Health Organization (WHO) reported that the world's population of people aged 60 years and older is growing rapidly and is expected to double by 2050, reaching 2.1 billion. Consequently, the growing aging population is a significant driver for the enteral nutrition market.

Product innovation stands out as a prominent trend gaining momentum in the enteral nutrition market. Leading companies within the enteral nutrition sector are dedicated to devising novel technological solutions and innovations to fortify their market standing. For instance, in August 2023, VGM Wound Care, a UK-based community and resource center catering to healthcare providers and vendors, particularly specializing in wound care, introduced the Enteral Nutrition Guide. This comprehensive resource offers crucial insights, protocols, and guidance for the seamless integration of enteral nutrition into the wound care business of HME (Home Medical Equipment) providers. VGM Wound Care's Enteral Nutrition Guide represents a significant advancement for wound care businesses striving to enhance patient care and diversify their service offerings. With comprehensive information and guidance, this resource empowers HME providers to effortlessly incorporate enteral nutrition into their wound care operations.

Prominent companies in the enteral nutrition market are directing their efforts towards the development of next-generation enteral feeding systems, such as enteral feeding pumps, to solidify their market presence. The Kangaroo OMNI Enteral Feeding Pump, a cutting-edge enteral feeding system, is engineered to deliver nutrition and hydration seamlessly from hospital to home. For example, in September 2023, Cardinal Health Inc., a US-based healthcare company, unveiled the Kangaroo OMNI enteral feeding pump. This pump is crafted to address the enteral feeding needs of patients and caregivers, offering the lightest, smallest, and quietest Kangaroo feed and flush enteral feeding pump while facilitating the delivery of a broader range of commercially available enteral formulas to patients.

In April 2023, Danone, a France-based foods group, completed the acquisition of Promedica for an undisclosed amount. This strategic move aligns with Danone's revitalization plan, focusing on investing in valuable brands and innovation while divesting underperforming assets. Promedica, based in Poland, specializes in home care services for patients.


Major companies operating in the enteral nutrition market report are Cardinal Health Inc., Nestle S.A., Fresenius Kabi AG, Abbott Laboratories, Medtronic Inc., Danone S.A., Becton, Dickinson and Company, Otsuka Pharmaceutical Factory, Boston Scientific Corporation, Hormel Foods Corporation, B. Braun Melsungen AG, Reckitt Benckiser Group PLC, Meiji Holdings Co. Ltd., C. R. Bard GmbH, Moog Inc., Mead Johnson Nutrition, Cook Medical, Halyard Health Inc., Avanos Medical Inc., Applied Medical, Angiplast Pvt Ltd., Kate Farms, Global Health Products Inc., Victus Inc., VYGON SAS.

North America was the largest region in the enteral nutrition market in 2023. The regions covered in the enteral nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the enteral nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products within the enteral nutrition category include standard enteral nutrition and enteral nutrition formulated for chronic illnesses. Standard enteral nutrition involves delivering nutrition through a tube directly into the gastrointestinal tract. It is formulated to fulfill the nutritional requirements of individuals who cannot consume sufficient amounts of food orally or have a malfunctioning gastrointestinal system. The nutrient composition comprises proteins, carbohydrates, multivitamins, antioxidants, amino acids, fibers, minerals, and other essential elements suitable for both adults and pediatric patients dealing with conditions such as cancer, critical care, diabetes, gastrointestinal diseases, and more. Enteral nutrition products are accessible through hospital pharmacies, retail pharmacies, and online pharmacies.

The enteral nutrition market research report is one of a series of new reports that provides enteral nutrition market statistics, including the enteral nutrition industry's global market size, regional shares, competitors with a enteral nutrition market share, detailed enteral nutrition market segments, market trends, and opportunities, and any further data you may need to thrive in the enteral nutrition industry. This enteral nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The enteral nutrition market includes revenues earned by providing nutrients, fats and other component through the feeding tube, management of malnutrition, dietary management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.